SCM
HRMY icon

Sterling Capital Management’s Harmony Biosciences HRMY Stock Holding History

Sterling Capital Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$295K Buy
8,114
+2,375
+41% +$74.9K 0.01% 1074
2026
Q1 		$161K Sell
5,739
-3,152
-35% -$103K ﹤0.01% 1259
2025
Q4 		$333K Buy
8,891
+715
+9% +$23.5K 0.01% 1142
2025
Q3 		$225K Hold
8,176
– – ﹤0.01% 1288
2025
Q2 		$258K Buy
8,176
+67
+0.8% +$2.15K ﹤0.01% 1204
2025
Q1 		$269K Sell
8,109
-850
-9% -$30.5K ﹤0.01% 1130
2024
Q4 		$308K Buy
8,959
+9
+0.1% +$309 ﹤0.01% 1157
2024
Q3 		$358K Buy
+8,950
New +$314K ﹤0.01% 1053

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sterling Capital Management's HRMY Position: Q2 2026 in Review

Sterling Capital Management increased its Harmony Biosciences (HRMY) stake by 41% in Q2 2026, buying an estimated $74.9K and bringing the position to 8,114 shares worth $295K. The position accounts for 0.01% of the portfolio, ranked #1074.

Sterling Capital Management first reported a position in HRMY in Q3 2024 and has held it in 8 quarters since. The position peaked at $358K in Q3 2024. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Sterling Capital Management held 8,114 shares of Harmony Biosciences worth $295K as of Q2 2026.
  • Sterling Capital Management bought 2,375 Harmony Biosciences shares in Q2 2026, an estimated $74.9K.
  • Harmony Biosciences made up 0.01% of Sterling Capital Management's portfolio in Q2 2026, its #1074 holding.
  • Sterling Capital Management first reported a position in Harmony Biosciences in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Harmony Biosciences position peaked at $358K in Q3 2024.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.